BioTissue Holdings, Inc.
Clinical Trials
4
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.
- Conditions
- Dry EyeDry Eye Disease (DED)Dry Eye Disease With Severe Keratitis
- Interventions
- Biological: Saline (NaCl 0,9 %) (placebo)
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- BioTissue Holdings, Inc
- Target Recruit Count
- 72
- Registration Number
- NCT06780306
- Locations
- 🇺🇸
Wilmington Eye at Brunswick Forest, Leland, North Carolina, United States
🇺🇸CORE, Inc. / Vita Eye Clinic, Shelby, North Carolina, United States
🇺🇸Eye Associates of North Jersey, Dover, New Jersey, United States
TTAX03 for the Treatment of Lumbosacral Facet Joint Pain
- Conditions
- Facet Joint Pain
- Interventions
- Biological: TTAX03 25mgBiological: TTAX03 10mg
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- BioTissue Holdings, Inc
- Target Recruit Count
- 36
- Registration Number
- NCT06236308
Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA
- Conditions
- Knee OsteoarthritisKnee ArthritisKnee Pain Chronic
- Interventions
- Biological: Saline
- First Posted Date
- 2021-10-15
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- BioTissue Holdings, Inc
- Target Recruit Count
- 90
- Registration Number
- NCT05079035
- Locations
- 🇺🇸
UAB Orthopaedic Surgery, Birmingham, Alabama, United States
🇺🇸Alabama Orthopaedic Center, Birmingham, Alabama, United States
🇺🇸Tuscon Orthopedic Institute, Tucson, Arizona, United States
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
- Conditions
- Non-healing Diabetic Foot UlcerDiabetic Foot InfectionNon-healing Wound
- Interventions
- Other: Standard care
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- BioTissue Holdings, Inc
- Target Recruit Count
- 106
- Registration Number
- NCT04450693
- Locations
- 🇺🇸
LakeView Clinical Research, Guntersville, Alabama, United States
🇺🇸Banner University Medical Center Tucson, Tucson, Arizona, United States
🇺🇸Clemente Clinical Research, Los Angeles, California, United States